3,3',4,4'-Biphenyltetramine tetrahydrochloride structure
|
Common Name | 3,3',4,4'-Biphenyltetramine tetrahydrochloride | ||
---|---|---|---|---|
CAS Number | 7411-49-6 | Molecular Weight | 360.110 | |
Density | N/A | Boiling Point | 481.7ºC at 760 mmHg | |
Molecular Formula | C12H18Cl4N4 | Melting Point | 300°C | |
MSDS | Chinese USA | Flash Point | 282.7ºC | |
Symbol |
GHS07, GHS08 |
Signal Word | Danger |
Use of 3,3',4,4'-Biphenyltetramine tetrahydrochloride3,3'-Diaminobenzidine(DAB) is an organic compound that is both chemically and thermodynamically stable; DAB has been used in immunohistochemical staining of nucleic acids and proteins. |
Name | 3,3',4,4'-Biphenyltetramine tetrahydrochloride |
---|---|
Synonym | More Synonyms |
Description | 3,3'-Diaminobenzidine(DAB) is an organic compound that is both chemically and thermodynamically stable; DAB has been used in immunohistochemical staining of nucleic acids and proteins. |
---|---|
Related Catalog | |
References |
[1]. Hannetz Roschzttardtz, et al. Plant Cell Nucleolus as a Hot Spot for Iron. |
Boiling Point | 481.7ºC at 760 mmHg |
---|---|
Melting Point | 300°C |
Molecular Formula | C12H18Cl4N4 |
Molecular Weight | 360.110 |
Flash Point | 282.7ºC |
Exact Mass | 358.028564 |
PSA | 104.08000 |
LogP | 7.21520 |
Water Solubility | Soluble |
Synonym:3,3',4,4'-Biphenyltetramine tetrahydrochloride; 3,3',4,4'-Tetraaminobiphenyl tetrahydrochloride Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 33 36/37/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Danger of cumulative effects. Irritating to eyes, respiratory system and skin.Cancer suspect agent. Potential Health Effects Eye: Causes eye irritation. May cause chemical conjunctivitis. Skin: Causes skin irritation. Ingestion: May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Inhalation: Causes respiratory tract irritation. Can produce delayed pulmonary edema. Chronic: Effects may be delayed. Animal studies have reported the development of tumors. Potential cancer hazard. Section 4 - FIRST AID MEASURES Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Ingestion: Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep refrigerated. (Store below 4C/39F.) Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 7411-49-6: United States OSHA: (Cancer suspect agent - see 29 CFR 1910.1010) (listed under Benzidine). France - VME: (listed as benzidine): 0.001 ppm VME; 0.008 mg/m3 V Germany: (listed as benzidine): 0.001 ppm VME; 0.008 mg/m3 VME Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Powder Color: off-white to gray Odor: none reported pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 280 deg C Autoignition Temperature: Not applicable. Flash Point: Not applicable. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: C12H14N4.4HCl.2H2O Molecular Weight: 396.14 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Incompatible materials, strong oxidants, strong oxidants. Incompatibilities with Other Materials: Strong oxidizing agents. Hazardous Decomposition Products: Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, nitrogen. Hazardous Polymerization: Has not been reported. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 7411-49-6: DV8753000 LD50/LC50: Not available. Carcinogenicity: 3,3'-Diaminobenzidine tetrahydrochloride - California: carcinogen, initial date 2/27/87 (listed as Benzidine). NTP: Known carcinogen (listed as Benzidine). IARC: Group 1 carcinogen (listed as Benzidine). Other: See actual entry in RTECS for complete information. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Shipping Name: Not regulated. Hazard Class: UN Number: Packing group: Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XI Risk Phrases: R 33 Danger of cumulative effects. R 36/37/38 Irritating to eyes, respiratory system and skin. Safety Phrases: S 22 Do not breathe dust. S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 7411-49-6: No information available. Canada CAS# 7411-49-6 is listed on Canada's DSL List. CAS# 7411-49-6 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 7411-49-6 is listed on the TSCA inventory. SECTION 16 - ADDITIONAL INFORMATION N/A |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H319-H341-H350 |
Precautionary Statements | P201-P280-P301 + P312 + P330-P305 + P351 + P338-P308 + P313-P337 + P313 |
Hazard Codes | Xn:Harmful; |
Risk Phrases | R22;R36/37/38;R40 |
Safety Phrases | S7-S16-S24-S33-S36/37-S45-S24/25-S22 |
RIDADR | UN 3316 9/PG 2 |
WGK Germany | 3 |
RTECS | DV8753000 |
Hazard Class | 9.0 |
Time- and dose-dependent induction of HSP70 in Lemna minor exposed to different environmental stressors.
Bull. Environ. Contam. Toxicol. 87(3) , 226-30, (2011) The objective of this study was to examine the influence of different stressors, including cadmium (heavy metal), anthracene (polycyclic aromatic hydrocarbon-PAH) and chloridazon (herbicide), on popul... |
|
The bioanalysis of trastuzumab in human serum using precipitate-enhanced ellipsometry.
Anal. Biochem. 393 , 73-79, (2009) For the bioanalysis of therapeutic monoclonal antibodies in biological matrices, immunoassays--especially enzyme-linked immunosorbent assays (ELISAs)--are the most widely used techniques. Although ELI... |
|
Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry.
J. Histochem. Cytochem. 30 , 1079-1082, (1982) Three metallic ions, NiCl2, CoCl2, and CuSO4, were found to modify the color of the normally brown diaminobenzidine (DAB) reaction. The colors ranged from purplish blue (NiCl2), dark blue/bluish black... |
DAB TABLET |
DAB SUBSTRATE |
DAB-HCL |
Biphenyl-3,3',4,4'-tetramine tetrahydrochloride |
DAB TETRAHYDROCHLORIDE |
DAB |
3,3',4,4'-Biphenyltetramine tetrahydrochloride |
DAB,tetrahydrochloride3 |
3,3`-Diaminobenzidine tetrahydrochloride |
DAB EASY tablets |
DAB anhydrous |
MFCD00012969 |
[1,1'-Biphenyl]-3,3',4,4'-tetramine, hydrochloride (1:4) |
DAB 4HCL |
EINECS 231-018-9 |
DAB WITH METAL ENHANCER |